Characterization of self-assembled virus-like particles of Merkel cell polyomavirus

PLoS One. 2015 Feb 11;10(2):e0115646. doi: 10.1371/journal.pone.0115646. eCollection 2015.

Abstract

In our recombinant baculovirus system, VP1 protein of merkel cell polyomavirus (MCPyV), which is implicated as a causative agent in Merkel cell carcinoma, was self-assembled into MCPyV-like particles (MCPyV-LP) with two different sizes in insect cells, followed by being released into the culture medium. DNA molecules of 1.5- to 5-kb, which were derived from host insect cells, were packaged in large, ~50-nm spherical particles but not in small, ~25-nm particles. Structure reconstruction using cryo-electron microscopy showed that large MCPyV-LPs are composed of 72 pentameric capsomeres arranged in a T = 7 icosahedral surface lattice and are 48 nm in diameter. The MCPyV-LPs did not share antigenic determinants with BK- and JC viruses (BKPyV and JCPyV). The VLP-based enzyme immunoassay was applied to investigate age-specific prevalence of MCPyV infection in the general Japanese population aged 1-70 years. While seroprevalence of MCPyV increased with age in children and young individuals, its seropositivity in each age group was lower compared with BKPyV and JCPyV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Animals
  • Baculoviridae / genetics
  • Capsid Proteins / genetics
  • Capsid Proteins / isolation & purification
  • Capsid Proteins / metabolism*
  • Cell Line
  • Child
  • Child, Preschool
  • Gene Expression
  • Humans
  • Infant
  • Insecta
  • JC Virus / immunology
  • Japan
  • Merkel cell polyomavirus* / genetics
  • Merkel cell polyomavirus* / metabolism
  • Middle Aged
  • Polyomavirus Infections / immunology
  • Young Adult

Substances

  • Capsid Proteins

Grants and funding

This study was supported in part by grants for Research on Emerging and Re-emerging Infectious Diseases, Research on Hepatitis, and Research on Food Safety from the Ministry of Health, Labour, and Welfare of Japan (to TL and TS), and by the Platform for drug discovery, informatics and structural life science (to KI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.